Cargando…
Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363008/ https://www.ncbi.nlm.nih.gov/pubmed/30774766 http://dx.doi.org/10.18632/oncotarget.26625 |
| _version_ | 1783393039746596864 |
|---|---|
| author | Evans, Jonathan P. Winiarski, Boleslaw K. Sutton, Paul A. Jones, Robert P. Ressel, Lorenzo Duckworth, Carrie A. Pritchard, D. Mark Lin, Zhi-Xiu Fretwell, Vicky L. Tweedle, Elizabeth M. Costello, Eithne Goldring, Christopher E. Copple, Ian M. Park, B. Kevin Palmer, Daniel H. Kitteringham, Neil R. |
| author_facet | Evans, Jonathan P. Winiarski, Boleslaw K. Sutton, Paul A. Jones, Robert P. Ressel, Lorenzo Duckworth, Carrie A. Pritchard, D. Mark Lin, Zhi-Xiu Fretwell, Vicky L. Tweedle, Elizabeth M. Costello, Eithne Goldring, Christopher E. Copple, Ian M. Park, B. Kevin Palmer, Daniel H. Kitteringham, Neil R. |
| author_sort | Evans, Jonathan P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6363008 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63630082019-02-15 Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer Evans, Jonathan P. Winiarski, Boleslaw K. Sutton, Paul A. Jones, Robert P. Ressel, Lorenzo Duckworth, Carrie A. Pritchard, D. Mark Lin, Zhi-Xiu Fretwell, Vicky L. Tweedle, Elizabeth M. Costello, Eithne Goldring, Christopher E. Copple, Ian M. Park, B. Kevin Palmer, Daniel H. Kitteringham, Neil R. Oncotarget Correction Impact Journals LLC 2019-01-18 /pmc/articles/PMC6363008/ /pubmed/30774766 http://dx.doi.org/10.18632/oncotarget.26625 Text en Copyright: © 2019 Evans et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Evans, Jonathan P. Winiarski, Boleslaw K. Sutton, Paul A. Jones, Robert P. Ressel, Lorenzo Duckworth, Carrie A. Pritchard, D. Mark Lin, Zhi-Xiu Fretwell, Vicky L. Tweedle, Elizabeth M. Costello, Eithne Goldring, Christopher E. Copple, Ian M. Park, B. Kevin Palmer, Daniel H. Kitteringham, Neil R. Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer |
| title | Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer |
| title_full | Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer |
| title_fullStr | Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer |
| title_full_unstemmed | Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer |
| title_short | Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer |
| title_sort | correction: the nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363008/ https://www.ncbi.nlm.nih.gov/pubmed/30774766 http://dx.doi.org/10.18632/oncotarget.26625 |
| work_keys_str_mv | AT evansjonathanp correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT winiarskiboleslawk correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT suttonpaula correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT jonesrobertp correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT ressellorenzo correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT duckworthcarriea correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT pritcharddmark correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT linzhixiu correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT fretwellvickyl correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT tweedleelizabethm correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT costelloeithne correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT goldringchristophere correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT coppleianm correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT parkbkevin correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT palmerdanielh correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer AT kitteringhamneilr correctionthenrf2inhibitorbrusatolisapotentantitumouragentinanorthotopicmousemodelofcolorectalcancer |